pre-IPO PHARMA

COMPANY OVERVIEW

Silverback Therapeutics is a biotechnology company based in Seattle, Washington, and founded in 2016.


LOCATION

  • Seattle, WA, USA

  • THERAPEUTIC AREAS


    WEBSITE

    None


    CAREER WEBSITE

    None


    SOCIAL MEDIA


    INVESTORS



    PRESS RELEASES


    Dec 8, 2020

    Silverback Therapeutics Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares


    Dec 3, 2020

    Silverback Therapeutics Announces Pricing of Initial Public Offering


    Nov 13, 2020

    Silverback Therapeutics Presents Preclinical Data for SBT8230 at AASLD The Liver Meeting Digital Experience


    Nov 10, 2020

    Silverback Therapeutics Expands Executive Team With Appointment of Healthcare Investment Banking Veteran Jonathan Piazza as Chief Financial Officer


    Nov 9, 2020

    Silverback Therapeutics to Present Data on Two Programs at The Society for Immunotherapy of Cancer’s (SITC) 35th Anniversary Annual Meeting


    For More Press Releases


    Google Analytics Alternative